Mode
Text Size
Log in / Sign up

Cortical atrophy (GCA 1 vs. 0) associated with lower functional independence in women with ischemic strokeBrain frailty markers impact recovery for women after stroke

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that cortical atrophy is associated with lower functional independence in women with ischemic stroke.

This study is a post-hoc analysis of a randomized trial involving patients with ischemic stroke who underwent endovascular thrombectomy (EVT) for large vessel occlusion. The study population included 1102 patients with non-contrast computed tomography (NCCT) and 568 patients with magnetic resonance imaging (MRI). The primary objective was to evaluate the association between various brain frailty markers and 90-day functional outcomes.

The researchers analyzed several specific brain frailty markers, including the global cortical atrophy (GCA) scale, subcortical atrophy, Fazekas score, lacunes, old infarctions, perivascular spaces, and microbleeds. The primary outcome measure was the modified Rankin Scale (mRS) score of 0-2 at 90 days. The study also included secondary outcomes focusing on perivascular spaces and microbleeds.

Regarding the primary outcome, the analysis investigated sex interactions between brain frailty markers and 90-day outcomes. The study reported that no significant sex interactions were identified. However, when examining specific associations for the GCA scale, a notable difference was observed between sexes. For women, the association of cortical atrophy (GCA 1 vs. 0) with mRS 0-2 showed a lower likelihood of achieving functional independence, with an effect size of 0.54 (95% CI 0.32-0.91). In contrast, for men, the association of cortical atrophy (GCA 1 vs. 0) with mRS 0-2 showed no clear association, with an effect size of 0.76 (95% CI 0.45-1.28).

Safety and tolerability data, including adverse event rates, serious adverse events, and discontinuation rates, were not reported in this analysis. The study focused on the prognostic value of pre-existing structural markers rather than the acute effects of a specific intervention.

These results contribute to the understanding of prognostic markers in ischemic stroke. While the study identifies a specific association in women, it is important to note that these exploratory sex-stratified analyses were not statistically significant for sex-by-brain frailty interactions. The findings suggest that brain frailty markers may have different prognostic implications based on sex, though the evidence is limited by the exploratory nature of the analysis.

Several methodological limitations exist. The study is a post-hoc analysis, which can increase the risk of type I errors when performing multiple comparisons. Furthermore, the exploratory sex-stratified analyses were not statistically significant for sex-by-brain frailty interactions. These factors mean the results should be viewed as preliminary.

Clinically, these findings suggest that brain frailty should be considered a prognostic marker for functional independence in patients with large vessel occlusion, regardless of sex. However, the specific association found in women regarding cortical atrophy requires cautious interpretation due to the lack of statistical significance in the interaction analysis. Questions remain regarding the specific impact of other markers, such as microbleeds or perivascular spaces, on long-term outcomes, and whether these associations remain consistent in larger, prospective cohorts.

How this fits prior evidence

How this fits prior evidence This finding extends the understanding of prognostic markers in stroke patients undergoing endovascular therapy. It builds upon previous findings where nerinetide showed no significant association with brain volume changes in stroke patients receiving endovascular therapy. While the current study focuses on pre-existing frailty markers rather than drug effects, it contributes to the characterization of structural markers in the same patient population.

When someone suffers a major stroke, the goal of medical treatment is to restore independence as quickly as possible. Doctors often look for ways to predict who will recover well and who might face more challenges. One specific area of focus is brain frailty. This term refers to signs of aging or wear and tear on the brain, such as the thinning of brain tissue or the presence of small old injuries. Understanding these factors helps doctors provide better care and set realistic expectations for patients and their families.

Researchers looked at a large group of patients who had a type of stroke involving a large blocked blood vessel. These patients underwent a procedure called an endovascular thrombectomy, which is a way to physically remove the clot. The researchers analyzed data from over 1,100 patients to see how different markers of brain frailty related to their recovery. They specifically looked at something called cortical atrophy, which is the loss of brain tissue, and how it affected patients' ability to function independently three months after the stroke.

The results showed an interesting pattern regarding how these markers affected different people. For men in the study, there was no clear link between brain tissue loss and their recovery outcomes. However, for women, the data showed a different trend. Women with signs of cortical atrophy were less likely to achieve functional independence after their stroke. This suggests that for women, these specific signs of brain aging might be a more significant indicator of how the body handles a major stroke event.

It is important to keep these findings in perspective. This specific analysis was exploratory, meaning the researchers were looking for patterns rather than testing a definitive rule. Because of this, the findings regarding the difference between men and women were not statistically significant. In other words, while the trend for women was noticeable, the study was not large enough or designed specifically to prove that sex plays a definitive role in how these markers work. For patients and families right now, this research does not change immediate treatment plans. Instead, it highlights that brain frailty is an important factor for everyone, regardless of sex. It tells doctors that looking at the overall health and age of the brain is a valuable way to predict recovery. While this study is just one piece of the puzzle, it encourages researchers to look closer at how different factors might affect women and men differently after a stroke.

What this means for you:
Brain frailty markers are important indicators of recovery for all patients after a stroke, regardless of sex.

Study Details

Study typeRct
Sample sizen = 1,102
EvidenceLevel 2
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: Brain frailty, characterized by atrophy and/or chronic vascular lesions, is associated with worse outcomes after endovascular thrombectomy (EVT), but whether its impact differs by sex remains unclear. Therefore, we investigated sex differences in the association between imaging brain frailty markers and 90-day outcome after EVT. METHODS: We conducted a post-hoc analysis of the ESCAPE-NA1 randomized trial, which evaluated intravenous nerinetide in patients undergoing EVT for acute ischemic stroke due to large vessel occlusion. Brain frailty markers-including global cortical atrophy (GCA) scale, subcortical atrophy, Fazekas score, lacunes, and old infarctions-were assessed on baseline non-contrast CT (NCCT), and among those with follow-up MRI, perivascular spaces and microbleeds were also evaluated. The primary outcome was a modified Rankin Scale (mRS) score of 0-2 at 90 days. Multivariable logistic regression was performed, stratified by sex. RESULTS: Among 1102 patients with NCCT (568 with MRI), no significant sex interactions were identified between brain frailty markers and 90-day outcomes. However, exploratory sex-stratified analyses showed that several brain frailty markers were associated with a lower likelihood of achieving functional independence (mRS 0-2) at 90 days in women, whereas no clear associations were observed in men. For example, cortical atrophy was associated with a lower likelihood of achieving an mRS score of 0-2 in women but not in men (adjusted OR for GCA 1 vs. 0: 0.54, 95% CI 0.32-0.91 in women; 0.76, 95% CI 0.45-1.28 in men). Similar patterns were observed for subcortical atrophy. CONCLUSIONS: Although sex-stratified analyses suggested nominal differences, no statistically significant sex-by-brain frailty interactions were observed. Brain frailty should be considered a prognostic marker irrespective of sex, and these exploratory findings warrant further investigation in adequately powered studies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.